4//SEC Filing
Gould Robert J 4
Accession 0000899243-23-001803
CIK 0001680581other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 6:33 PM ET
Size
4.8 KB
Accession
0000899243-23-001803
Insider Transaction Report
Form 4
Gould Robert J
Director
Transactions
- Sale
Common Stock
2023-01-13$15.00/sh−6,766$101,490→ 499,864 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2022.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001577034
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 6:33 PM ET
- Size
- 4.8 KB